AKR1B10 can change the retinoic acid synthesis pathway and participate in the occurrence and development of tumors.[18] It is extensively expressed in the stomach and intestine epithelial cells, but down-regulated in gastrointestinal carcinoma and inflammatory bowel disease. This evidence concerns the gene AKR1B10 and digestive system carcinoma.